HDAC6-Catalyzed α-Tubulin Lactylation: Linking Metabolism and Microtubule Dynamics

Study Background and Research Question

Microtubules, dynamic polymers of α/β-tubulin heterodimers, are central to numerous cellular functions, including intracellular transport, cell migration, and division. Their functional diversity is tightly regulated by post-translational modifications (PTMs)—collectively known as the "tubulin code"—which determine microtubule stability, interaction with motor proteins, and spatial dynamics in specialized cellular compartments (reference). While acetylation, detyrosination, and polyglutamylation are well-characterized PTMs, the full spectrum of modifications and their regulatory mechanisms remain incompletely understood. Recent discoveries of protein lactylation, a PTM derived from lactate, have primarily focused on histones and metabolic enzymes. Whether lactylation directly modulates the cytoskeleton, and how metabolic state influences microtubule dynamics via such modifications, were open questions. This study addresses whether α-tubulin undergoes lactylation, the enzymes responsible, and the functional consequences for microtubule behavior in neurons.

Key Innovation from the Reference Study

The pivotal advance reported by Li et al. is the identification of lactylation at lysine 40 (K40) on α-tubulin, catalyzed by the deacetylase HDAC6 (reference). This modification is reversible and responds dynamically to intracellular lactate concentrations, directly linking metabolic state to cytoskeletal remodeling. Importantly, the study demonstrates that α-tubulin lactylation promotes microtubule dynamics, facilitating neurite outgrowth and branching in cultured hippocampal neurons. These findings assign a novel, non-histone role to HDAC6 as a primary “writer” of tubulin lactylation, expanding the functional repertoire of the tubulin code.

Methods and Experimental Design Insights

To dissect the mechanisms underlying α-tubulin lactylation, the authors combined a suite of biochemical, imaging, and genetic approaches:

• Mass spectrometry identified lactylated lysine residues on α-tubulin, confirming K40 as the primary site, and distinguished this modification from acetylation at the same residue.
• Site-directed mutagenesis was employed to generate K40R mutants, establishing the specificity of lactylation to this residue.
• In vitro enzymatic assays demonstrated direct lactylation of α-tubulin by purified HDAC6 in the presence of lactate, indicating that HDAC6 serves as both a deacetylase and a lactylase, with activity dependent on lactate concentration.
• Immunofluorescence and live-cell imaging tracked the distribution of lactylated α-tubulin and monitored microtubule dynamics and neurite extension in primary hippocampal neurons under varying lactate conditions.
• Pharmacological inhibition of HDAC6 confirmed the enzyme’s central role in mediating α-tubulin lactylation and its downstream effects on microtubule behavior.

This integrative approach robustly links enzymatic activity, metabolic cues, and cytoskeletal function.

Core Findings and Why They Matter

The study's major findings can be summarized as follows:

• Discovery of α-tubulin lactylation at K40: Mass spectrometry revealed lactylation as a new PTM on the soluble fraction of α-tubulin dimers, distinct from the acetylated, microtubule-incorporated pool (reference).
• HDAC6 as the primary lactylase: HDAC6, previously known primarily for deacetylating α-tubulin, is shown to catalyze the addition of lactyl groups to K40 in a lactate-dependent manner. This activity is conserved among HDAC family members but is most pronounced in HDAC6 (reference).
• Functional outcome—enhanced microtubule dynamics: Lactylated α-tubulin increases microtubule dynamic instability, as evidenced by greater neurite outgrowth and branching in cultured neurons. This effect is reversible, consistent with fluctuating lactate levels during metabolic shifts.
• Competition with acetylation at K40: Lactylation and acetylation occur at the same lysine residue, suggesting a competitive regulatory mechanism whereby metabolic state may shift the balance between microtubule stability (acetylation) and dynamics (lactylation).
• Implications for neuronal development and disease: Given the essential role of microtubule dynamics in axonal guidance, branching, and transport, this regulatory axis could impact neurodevelopmental processes and potentially inform models of neurodegenerative disease (reference).

The mechanistic link between metabolism and cytoskeletal function opens new avenues for exploring how metabolic disturbances might contribute to cytoskeletal defects in disease.

Comparison with Existing Internal Articles

Internal resources provide context for the study’s innovation, particularly regarding research tools and assay design:

• The article "Nocodazole: Precision Microtubule Polymerization Inhibitor" discusses how Nocodazole, a reversible tubulin inhibitor, is utilized for precise disruption of microtubule dynamics and cell cycle regulation assays, complementing studies of microtubule PTMs (internal).
• "Nocodazole in Focus: Decoding Microtubule Dynamics and Metabolic Signaling" bridges the role of metabolic state and microtubule behavior, aligning with the present findings that lactate-driven PTMs regulate cytoskeletal function (internal).
• These resources reinforce the utility of microtubule polymerization inhibitors, like Nocodazole, for dissecting the relationship between PTMs and cytoskeletal dynamics in various biological contexts.

Protocol Parameters

• cell cycle regulation assay | 25 nM – 1 μM Nocodazole | mammalian cell lines (e.g., SH-SY5Y, NRK fibroblasts) | Standard range for reversible microtubule depolymerization and arrest at G2/M; useful for synchronizing cells or interrogating PTM effects on mitotic progression | product_spec
• microtubule dynamics research | 100 nM – 500 nM Nocodazole | live-imaging of neuronal or fibroblast cultures | Enables acute, reversible disruption of microtubule polymerization, facilitating observation of PTM-dependent dynamic instability | workflow_recommendation
• anticancer drug evaluation | 1 μM Nocodazole (with/without metabolic modulators) | preclinical cancer models | Allows assessment of PTM interplay and drug synergy in apoptosis or cell cycle arrest | product_spec
• solvent preparation | ≥15 mg/mL Nocodazole in DMSO | stock solution for in vitro/in vivo assays | Ensures optimal solubility; warm to 37°C and use ultrasonic shaking for complete dissolution | product_spec

Limitations and Transferability

While this work establishes α-tubulin lactylation as a key regulator of microtubule dynamics in neuronal cells, several caveats remain:

• The interplay between lactylation and other PTMs at K40 (notably acetylation and methylation) requires further clarification, particularly in non-neuronal lineages.
• Findings are primarily based on cultured hippocampal neurons; the relevance to other cell types or in vivo systems awaits validation (reference).
• Potential compensatory mechanisms among HDAC family proteins or alternative metabolic pathways may modulate the observed effects in complex tissues.
• The study employs pharmacological inhibition and overexpression, both of which can have off-target effects; future work using genetic knock-in/out models may better resolve specificity.

Nonetheless, the reversible nature of lactylation and its responsiveness to cellular lactate suggest broad applicability in models of metabolic adaptation, stress, or disease.

Research Support Resources

Researchers aiming to investigate the impact of metabolic state or PTMs on microtubule dynamics can implement reversible tubulin inhibitors such as Nocodazole (SKU A8487, APExBIO) for controlled perturbation of cytoskeletal assembly. Nocodazole’s established utility in cell cycle synchronization, microtubule dynamics research, and anticancer drug evaluation makes it suitable for studies probing the functional outcomes of tubulin modifications, including those described in the present study (product_spec). For optimal results, consider integrating Nocodazole with metabolic modulators to dissect the interplay between PTMs and cellular physiology in live-cell or biochemical assays. APExBIO provides detailed preparation and storage guidance to ensure experimental reproducibility.